BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24491356)

  • 1. Social construction and the evidence-based drug policy endeavour.
    Lancaster K
    Int J Drug Policy; 2014 Sep; 25(5):948-51. PubMed ID: 24491356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Naloxone works': The politics of knowledge in 'evidence-based' drug policy.
    Lancaster K; Treloar C; Ritter A
    Health (London); 2017 May; 21(3):278-294. PubMed ID: 28135864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010.
    Lancaster K; Ritter A
    Int J Drug Policy; 2014 Jan; 25(1):81-7. PubMed ID: 23931957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Producing the 'problem of drugs': A cross national-comparison of 'recovery' discourse in two Australian and British reports.
    Lancaster K; Duke K; Ritter A
    Int J Drug Policy; 2015 Jul; 26(7):617-25. PubMed ID: 25962733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of evidence and the expert in contemporary processes of governance: the case of opioid substitution treatment policy in England.
    Duke K; Thom B
    Int J Drug Policy; 2014 Sep; 25(5):964-71. PubMed ID: 24582381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ideation, social construction and drug policy: A scoping review.
    Gstrein V
    Int J Drug Policy; 2018 Jan; 51():75-86. PubMed ID: 29227842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evidence-based policy and sustainable translation of knowledge: a perspective for health promotion in Germany].
    Rütten A; Gelius P
    Gesundheitswesen; 2012 Apr; 74(4):224-8. PubMed ID: 22508260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The limitations of 'evidence-based' public health.
    Kemm J
    J Eval Clin Pract; 2006 Jun; 12(3):319-24. PubMed ID: 16722916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New directions in evidence-based policy research: a critical analysis of the literature.
    Oliver K; Lorenc T; Innvær S
    Health Res Policy Syst; 2014 Jul; 12():34. PubMed ID: 25023520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based policymaking: a critique.
    Greenhalgh T; Russell J
    Perspect Biol Med; 2009; 52(2):304-18. PubMed ID: 19395827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intelligent policy making? Key actors' perspectives on the development and implementation of an early years' initiative in Scotland's public health arena.
    Deas L; Mattu L; Gnich W
    Soc Sci Med; 2013 Nov; 96():1-8. PubMed ID: 24034945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based policy-making: the implications of globally-applicable research for context-specific problem-solving in developing countries.
    Behague D; Tawiah C; Rosato M; Some T; Morrison J
    Soc Sci Med; 2009 Nov; 69(10):1539-46. PubMed ID: 19781839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based decision-making 8: Health policy, a primer for researchers.
    Maddalena V
    Methods Mol Biol; 2015; 1281():501-17. PubMed ID: 25694330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone, a contested substance: Danish methadone policy in the 1970s.
    Houborg E
    Int J Drug Policy; 2013 Nov; 24(6):e73-80. PubMed ID: 24120441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences and attitudes towards evidence-informed policy-making among research and policy stakeholders in the Canadian agri-food public health sector.
    Young I; Gropp K; Pintar K; Waddell L; Marshall B; Thomas K; McEwen SA; Rajić A
    Zoonoses Public Health; 2014 Dec; 61(8):581-9. PubMed ID: 24528517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making drug policy together: reflections on evidence, engagement and participation.
    Roberts M
    Int J Drug Policy; 2014 Sep; 25(5):952-6. PubMed ID: 24882708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What prevents health policy being 'evidence-based'? New ways to think about evidence, policy and interventions in health.
    Lancaster K; Rhodes T
    Br Med Bull; 2020 Oct; 135(1):38-49. PubMed ID: 32897357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.